Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data

Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data

Abstract Background Treatment with onabotulinumtoxin A (BT-A) is safe and effective for chronic migraine (CM). Several studies assessed possible predictors of response to treatment with BT-A, but there is little knowledge on the frequency and predictors of sustained response. The aim of this study w...

Full description

Bibliographic Details
Main Authors: Raffaele Ornello, Simona Guerzoni, Carlo Baraldi, Luana Evangelista, Ilaria Frattale, Carmine Marini, Cindy Tiseo, Francesca Pistoia, Simona Sacco
Format: Article
Language:English
Published: BMC 2020-04-01
Series:The Journal of Headache and Pain
Subjects:
Headache
Migraine
Botulinum toxin
Response
Prevention
Open-label study
Online Access:http://link.springer.com/article/10.1186/s10194-020-01113-6

Internet

http://link.springer.com/article/10.1186/s10194-020-01113-6

Similar Items